Nombre del producto:Potassium thiocyanate

IUPAC Name:

CAS:333-20-0
Fórmula molecular:CKNS
Pureza:98%
Número de catálogo:CM000375
Peso molecular:97.18

Unidad de embalaje Stock disponible Precio($) Cantidad
CM000375-500g 1-2 Weeks ǕŔ

Sólo para uso en I+D..

Formulario de consulta

   refresh    

Detalles del producto

Núm. De CAS :333-20-0
Fórmula molecular:CKNS
Punto de fusión:-
Código de sonrisas:[S-]C#N.[K+]
Densidad:
Número de catálogo:CM000375
Peso molecular:97.18
Punto de ebullición:
Nº Mdl:MFCD00011413
Almacenamiento:

Column Infos

Crinecerfont
The New England Journal of Medicine publishes the primary CAHtalyst™ Adult Phase 3 study results of Crinecerfont for the treatment of congenital adrenal hyperplasia (CAH). Classic congenital adrenal hyperplasia (CAH) due to 21-hydroxylase deficiency (21OHD) is a rare genetic disorder, affected by a lack of cortisol and/or aldosterone. Corticotropin-releasing factor type 1 receptor (CRF1) antagonism is shown to clinically decrease ACTH production and adrenal androgen levels.
Neurocrine's Crinecerfont is an investigational, selective CRF1 antagonist being developed to reduce and control excess adrenocorticotropic hormone (ACTH) and adrenal androgens. The phase 3 study meets primary and important key secondary endpoints, including a significant reduction in androstenedione levels and lowering glucocorticoid dosing.